Betahistine attenuates murine collagen-induced arthritis by suppressing both inflammatory and Th17 cell responses

摘要

The objective of this study was to evaluate the potential therapeutic effects of betahistine dihydrochloride (betahistine) in a collagen-induced arthritis (CIA) mouse model. CIA was induced in DBA/1 male mice by primary immunization with 100 mu l of emulsion containing 2 mg/ml chicken type II collagen (CII) mixed with complete Freund's adjuvant (CFA) in an 1:1 ratio, and booster immunization with 100 mu l of emulsion containing 2 mg/ml CII mixed with incomplete Freund's adjuvant (IFA) in an 1:1 ratio. Immunization was performed subcutaneously at the base of the tail. After being boosted on day 21, betahistine (1 and 5 mg/kg) was orally administered daily for 2 weeks. The severity of CIA was determined by arthritic scores and assessment of histopathological joint destruction. Expression of cytokines in the paw and anti-CII antibodies in the serum was evaluated by ELISA. The proliferative response against CII in the lymph node cells was measured by H-3-thymidine incorporation assay. The frequencies of different CII specific CD4+ T cell subsets in the lymph node were determined by flow-cytometric analysis. Betahistine treatment attenuated the severity of arthritis and reduced the levels of pro-inflammatory cytokines, including TNF-alpha, IL-6, IL-23 and IL-17A, in the paw tissues of CIA mice. Lymph node cells from betahistinetreated mice showed a decrease in proliferation, as well as a lower frequency of Th17 cells. In vitro, betahistine suppressed CD4+ T cell differentiation into Th17 cells. These results indicate that betahistine is effective in suppressing both inflammatory and Th17 responses in mouse CIA and that it may have therapeutic value nark adjunct treatment for rheumatoid arthritis. (C) 2016 Elsevier B.V. All rights reserved.